IISc's upcoming Bagchi-Parthasarathy Hospital to get Geriatrics wing

Bengaluru: The Indian Institute of Science has entered into an MoU with Prashanth Prakash, founding partner of Accel and Chairman of Karnataka's Startup Vision Group, to set up a geriatrics wing as part of IISc's upcoming Bagchi-Parthasarathy Hospital. 

The Shantha & Prakash Geriatrics Wing is expected to be operational by the start of 2025, Bengaluru-based IISc said in a statement.

Also Read:Maha: Kokilaben Hospital to provide free bone-marrow transplants to marginalized children under Centre's scheme

The wing will be equipped with state-of-the-art facilities in geriatrics to support academic and research programmes, and to enable PG students to undergo world-class training, it said.

"It will take forward the IISc Medical School's objective of integrating science, engineering and medicine under a single umbrella to produce a new generation of physician-scientists," the statement said.

IISc Director Prof Govindan Rangarajan, Director, IISc, said despite advances in integrative medicine, long-term care including post-acute care of the elderly is a universal challenge.

With increasing life expectancy, he said, it is also crucial to ensure healthy aging of the population.

"These multiple challenges require an interdisciplinary approach for effective care and we are sure that the Shantha & Prakash Geriatrics Wing will fuel and drive the much-needed innovation in this space, Rangarajan added.

Prakash said proactively managing age-related comorbidities will help prolong the period during which individuals can enjoy maximum physical and cognitive independence.

"Through physician-scientists, there is immense potential for the Institute to bring advancements in Gerosciences and Healthy-aging to help people live their most extended, healthiest lives possible, he said.

Medical Dialogues team had earlier reported that Bharat Serums and Vaccines Ltd. (BSV), a biopharmaceutical company in India had announced a collaboration with the 'Evolutionary Venomics Lab', at the Indian Institute of Science (IISc) Bangalore to develop region-specific antivenoms, thereby, next-generation snakebite therapy in India.

Also Read:Odisha Govt signs MoU with Aster CMI Hospital for paediatric liver transplant